Skip to main content
. 2021 Sep 7;5:PO.20.00439. doi: 10.1200/PO.20.00439

FIG 2.

FIG 2.

Efficacy of ceralasertib and olaparib in a subset of patients with ATM mutation. (A) Waterfall plot of the best objective response measured as the maximum change from baseline in the sum of the longest diameter of each target lesion. (B) Swimmer plot demonstrating time to response and duration of study treatment. The table on the right defines the cohort, extent of response, ATM mutation details, and biallelic status. NE, non-evaluable; U, unknown.